Though sulfonylurea for treatment neonatal diabetes is supported by some researchers and clinicians, insulin treatment is still acutely required in most infants with newly diagnosed diabetes mellitus to treat or prevent ketoacidosis and dehydration. This evidence concerns the gene INS and diabetes mellitus.